---
figid: PMC3896370__pone.0085296.g006
figlink: /pmc/articles/PMC3896370/figure/pone-0085296-g006/
number: F6
caption: This schematic diagram demonstrates the inducing effect of CDH17 on Ras/Raf/MEK/ERK
  signaling pathway and illustrates the hypothetic involvement of integrins in GC.
  CDH17 indirectly affects integrins to stabilize their structure and activity. The
  up-regulation of cadherin-integrin signaling activates the Ras/Raf/MEK/ERK pathway.
  The activation of ERK regulates various nuclear and cytoplasmic substrates, including
  p53 and p21, which involve in diverse cellular responses, such as cell proliferation,
  migration, adhesion, colony formation, cell-cycle and apoptosis.
pmcid: PMC3896370
papertitle: Targeting Cadherin-17 Inactivates Ras/Raf/MEK/ERK Signaling and Inhibits
  Cell Proliferation in Gastric Cancer.
reftext: Zhaohu Lin, et al. PLoS One. 2014;9(1):e85296.
pmc_ranked_result_index: '988'
pathway_score: 0.9653561
filename: pone.0085296.g006.jpg
figtitle: Targeting Cadherin-17 Inactivates Ras/Raf/MEK/ERK Signaling and Inhibits
  Cell Proliferation in Gastric Cancer
year: '2014'
organisms: Homo sapiens
ndex: d126f140-ded2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3896370__pone.0085296.g006.html
  '@type': Dataset
  description: This schematic diagram demonstrates the inducing effect of CDH17 on
    Ras/Raf/MEK/ERK signaling pathway and illustrates the hypothetic involvement of
    integrins in GC. CDH17 indirectly affects integrins to stabilize their structure
    and activity. The up-regulation of cadherin-integrin signaling activates the Ras/Raf/MEK/ERK
    pathway. The activation of ERK regulates various nuclear and cytoplasmic substrates,
    including p53 and p21, which involve in diverse cellular responses, such as cell
    proliferation, migration, adhesion, colony formation, cell-cycle and apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRAS
  - KRAS
  - CDH17
  - HRAS
  - BRAF
  - RAF1
  - ARAF
  - MAPK3
  - MAPK1
  - TP53
  - MAP2K2
  - MAP2K1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: CDH17
  symbol: CDH17
  source: hgnc_symbol
  hgnc_symbol: CDH17
  entrez: '1015'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3896370__F6
redirect_from: /figures/PMC3896370__F6
figtype: Figure
---
